Create. The parties intend for the Joint Clinical Development to qualify for the benefits of the Cooperative Research and Technology Enhancement Act (35 U.S.C. § 103) (the “CREATE Act”). Accordingly, each party agrees to use reasonable efforts to do, and cause its employees to do, all lawful acts that may be or become necessary to evidence, maintain, record and perfect rights of the parties provided by the CREATE Act.
Appears in 3 contracts
Sources: Master Clinical Study Agreement, Master Clinical Study Agreement (Juno Therapeutics, Inc.), Master Clinical Study Agreement (Juno Therapeutics, Inc.)